e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Severe asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
High BMI in severe asthma is associated with co-morbid factors but not with increased airway inflammation or -obstruction
I. H. Van Veen, M. C. Timmers, E. H. Bel, A. ten Brinke (Leiden, Leeuwarden, The Netherlands)
Source:
Annual Congress 2002 - Severe asthma and COPD
Session:
Severe asthma and COPD
Session type:
Oral Presentation
Number:
2577
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. H. Van Veen, M. C. Timmers, E. H. Bel, A. ten Brinke (Leiden, Leeuwarden, The Netherlands). High BMI in severe asthma is associated with co-morbid factors but not with increased airway inflammation or -obstruction. Eur Respir J 2002; 20: Suppl. 38, 2577
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Specific comorbidities and low adherence are independent risk factors for poorer asthma control and exacerbations in patients with difficult-to-control asthma
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019
Leptin as a specific marker of risk factors in severe bronchial asthma
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009
Surrogate markers of airway inflammation are not increased in actively smoking mild to moderate asthmatics
Source: Eur Respir J 2001; 18: Suppl. 33, 283s
Year: 2001
Asthma in combination with rhinitis and eczema is associated with higher levels of type-2 inflammation and symptom burden
Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma
Year: 2021
Markers of systemic inflammation are associated with increased symptoms and respiratory exacerbations among smokers with preserved spirometry in SPIROMICS
Source: International Congress 2018 – Biomarkers in COPD and asthma
Year: 2018
The association between obesity and asthma: interactions between systemic and airway inflammation
Source: Annual Congress 2008 - Understanding airway inflammation
Year: 2008
Airway eosinophilia in severe asthma is associated with smoking history
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Decrease in smoking is related to a decrease in respiratory symptoms but not asthma
Source: Annual Congress 2011 - Genetic and environmental risk factors for respiratory diseases
Year: 2011
Airway hyperresponsiveness and smoking, but not atopy, are associated with moderate and severe-persistent respiratory disease: analysis of a longitudinal birth cohort
Source: Annual Congress 2005 - Highlights of asthma epidemiology
Year: 2005
Distribution of biomarkers in severe asthma and severe uncontrolled asthma
Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research
Year: 2021
Smoking and concomitant medication as risk factors for exacerbation of bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 45s
Year: 2005
Associations between inflammatory endotypes and phenotypes of obesity at young patients with bronchial asthma
Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities
Year: 2020
How does obesity correlate with severe asthma?
Source: Annual Congress 2011 - Airways disease comorbidities and general aspects
Year: 2011
Interaction between asthma and smoking increases the risk of adult airway obstruction
Source: Eur Respir J 2015; 45: 635-643
Year: 2015
Severe bronchial asthma: risk factors
Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Year: 2008
The effect of obesity or overweight on airway hyperresponsiveness and clinical features in patients with asthma
Source: Annual Congress 2011 - Asthma: risk factors and comorbidities
Year: 2011
Factors associated with asthma control in patients with stable asthma
Source: Annual Congress 2011 - Asthma: issues in rehabilitation and physical therapy
Year: 2011
Relationships between asthma, obesity and OSAS severity in children
Source: Virtual Congress 2021 – Respiratory physiology and breathing during sleep in health and sickness
Year: 2021
Uncontrolled asthma has a higher disease burden compared to controlled asthma in adult onset but not in childhood onset asthma
Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Year: 2020
The relationship between comorbidities and systemic inflammation in patients with COPD
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept